New synthetic heparin mimetics able to inhibit thrombin and factor Xa
- 1 April 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (8) , 1155-1160
- https://doi.org/10.1016/s0960-894x(99)00155-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- First Synthetic Carbohydrates with the Full Anticoagulant Properties of HeparinAngewandte Chemie International Edition in English, 1998
- Synthesis of Tailor‐Made Glycoconjugates Showing AT III‐Mediated Inhibition of Blood Coagulation Factors Xa and ThrombinAngewandte Chemie International Edition in English, 1996
- Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activityNature Structural & Molecular Biology, 1995
- Feasible synthesis and biological properties of six ‘non-glycosamino’ glycan analogues of the antithrombin III binding heparin pentasaccharideBioorganic & Medicinal Chemistry, 1994
- Regulation of Thrombin Activity by Antithrombin and HeparinSeminars in Thrombosis and Hemostasis, 1994
- The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic AntithromboticsAngewandte Chemie International Edition in English, 1993
- Further characterization of the antithrombin-binding sequence in heparinCarbohydrate Research, 1982
- The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studiesBiochemical Journal, 1981
- STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARINAnnals of the New York Academy of Sciences, 1981
- Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.Proceedings of the National Academy of Sciences, 1980